Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019

BACKGROUND: Coronavirus disease 2019 (COVID-19) is currently spreading worldwide. This study examined whether serum Krebs von den Lungen-6 (KL-6) level is a useful biomarker for evaluating the severity of COVID-19. METHODS: We retrospectively examined patients diagnosed with COVID-19 at the Japanese...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Respir Investig
Asıl Yazarlar: Awano, Nobuyasu, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Takada, Kohei, Muto, Yutaka, Fujimoto, Kazushi, Akagi, Yu, Mawatari, Momoko, Ueda, Akihiro, Izumo, Takehiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Japanese Respiratory Society. Published by Elsevier B.V. 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441928/
https://ncbi.nlm.nih.gov/pubmed/32863199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.resinv.2020.07.004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller